First Page | Meta Content | |
---|---|---|
Document Date: 2011-12-15 11:29:56Open Document File Size: 139,34 KBShare Result on FacebookCityRockville / Morin / Mojica / Wilmington / Philip / /CompanyAstraZeneca Pharmaceuticals LP. / F. & Solh A. A. E. / Am J Health Syst Pharm / Amiel SA / Carpenter / Forbes.com / Thomson Reuters (Healthcare) Inc. / /CountryUnited States / /CurrencyUSD / /EventFDA Phase / / /IndustryTermTreatment of sleep dysfunction / anger management / /MarketIndexTop 40 / /MedicalConditionmg/day Indication Major Depressive Disorder / Major Depressive Disorder / Adjunct Therapy Bipolar Depression / dementia / Substance Use Disorders / hallucinations / dysfunction / primary insomnia / diabetic ketoacidosis / mg Bipolar Mania / Chronic Insomnia / Bipolar Mania / Senile Dementia / hypotension / insomnia / insulin resistance / Alzheimer’s disease / Schizophrenia / I Disorder / Bipolar Depression / Dose / Maximum Recommended Dose Range Daily Dose Schizophrenia / post-traumatic stress disorder / hyperlipidemia / attention deficit hyperactivity disorder / psychiatric disorders / mood disorder / off-label insomnia / depression / comorbid psychiatric disorders / disorders / Bipolar disorder / /MedicalTreatmentadjunctive therapy / Pharmacotherapy / /OrganizationNational Institute of Health / Oregon FFS / Department of Justice / federal government / FDA / Drug Use Research & Management Program DHS Division of Medical Assistance Programs / /PersonSimon V / Depressive Disorder / Frederick S. Stinson / Bridget F. Grant / Wilson M. Compton / F. Grant Prevalence / / /PositionMajor / /Productrisperidone / Seroquel XR / olanzapine / clozapine / Seroquel / /ProvinceOrStateAlaska / Southern California / Oregon / Washington / Nova Scotia / /RegionSouthern California / /TVStationKoro / /URLhttp /SocialTag |